Kaplan-Meier survival analysis showed that patients with low expression of FAM13A-AS1 had significantly better overall survival rates (p = 0.0007) (Figure 1D), suggesting that FAM13A-AS1 could be a promising prognostic marker for RCC. The gene discussed is FAM13A; the disease is renal cell carcinoma.